- Home
- LSBK vs JSPR Comparison
LSBK vs JSPR Comparison
Compare LSBK & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LSBK | JSPR |
|---|---|---|
| Founded | 1891 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.0M | 48.1M |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | LSBK | JSPR |
|---|---|---|
| Price | $14.79 | $1.80 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $21.44 |
| AVG Volume (30 Days) | 12.4K | ★ 4.0M |
| Earning Date | 01-23-2026 | 11-10-2025 |
| Dividend Yield | ★ 2.43% | N/A |
| EPS Growth | ★ 105.28 | N/A |
| EPS | ★ 1.21 | N/A |
| Revenue | ★ $27,774,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.26 | ★ N/A |
| Revenue Growth | ★ 9.61 | N/A |
| 52 Week Low | $11.50 | $1.39 |
| 52 Week High | $16.95 | $22.99 |
Technical Indicators
Market Signals| Indicator | LSBK | JSPR |
|---|---|---|
| Relative Strength Index (RSI) | 55.90 | 50.28 |
| Support Level | $14.53 | $1.61 |
| Resistance Level | $14.98 | $1.96 |
| Average True Range (ATR) | 0.22 | 0.13 |
| MACD | -0.06 | 0.03 |
| Stochastic Oscillator | 38.94 | 63.89 |
Price Performance
Historical ComparisonAbout LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.